Profound Medical Corp has seen some notable movement in its stock price this week.
This week, Profound Medical Corp (PRN.TO) experienced a decline of 7.87%, closing at C$9.93, down 1.40% on Thursday. The stock's performance has been influenced by recent market dynamics and investor sentiment in the healthcare sector.
Advertisement
Profound Medical Corp
PRN.TO
PRN.TO
Profound Medical Corp
WealthAwesomeAdvertisement
Market cap
$353.93M
52W high
$12.40
52W low
$5.23
1W change
-13.29%
Beta
0.53
Analyst Price Targets
Based on analyst covering PRN
Wall Street analysts forecast PRN stock price to rise 157.5% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$25.03
+157.5% Upside
Current Price
C$9.72
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Advertisement
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on PRN's historical volatility
30-Day Vol
59.9%
Annualized
90-Day Vol
54.1%
Annualized
Trend (90d)
+9.2%
Annualized drift
90d Mean
C$10.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$9.83 | C$7.99 – C$12.08 |
| 60 trading days | C$9.93 | C$7.42 – C$13.31 |
| 90 trading days | C$10.04 | C$7.02 – C$14.37 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Investor takeaway: Investors should monitor the ongoing developments at Profound Medical, particularly as the company navigates market fluctuations and works towards improving its financial performance. The stock's current price is significantly below analyst targets, indicating potential for future growth if the company can stabilize its operations.
C$9.93 Closing Price
The stock closed at C$9.93, reflecting a significant drop from its 52-week high of C$12.40, indicating volatility and investor caution.
Bull case
Analysts are optimistic about Profound Medical, with an average target price of C$25.03. This suggests a potential upside of 152.1%. This positive outlook may be due to the company's innovative medical technologies and strong market positioning in the healthcare sector.
Bear case
However, the company faces challenges, including a significant negative profit margin of -206.8% and a return on equity of -70.6%. These financial hurdles highlight the risks associated with investing in Profound Medical, especially given the recent stock performance.
Recent Price Action
Advertisement
Profound Medical Corp's stock closed at C$9.93 on Thursday, reflecting a decline of 1.40% for the day. Over the past week, the stock has decreased by 7.87%, contributing to a year-to-date drop of 6.73%. Despite a modest gain of 4.24% over the past month, the overall trend remains concerning for investors.
Company News
On July 7, 2026, Profound Medical saw an 8.2% increase in its stock price, sparking discussions among investors about the sustainability of this upward movement. However, the recent downward trend suggests that market sentiment is currently leaning towards caution. Investors should stay informed about any forthcoming announcements or developments that could influence the stock's trajectory.
Technical Picture
The technical indicators show that Profound Medical's stock is trading above both its 50-day moving average of C$9.60 and its 200-day moving average of C$9.24, which are positive signs. The stock's 52-week range is between C$5.23 and C$12.40, indicating it is currently trading at 66% of its range. The beta of 0.53 suggests that the stock is less volatile compared to the broader market. With a trading volume of 4,089 shares, the recent activity is below the 20-day average volume of 14,174 shares, indicating reduced trading interest.
Advertisement
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
